SCL has been reported to improve dysmenorrhea and inflammation in dysmenorrhea models in vitro and in vivo via suppressing the Ca2+/MLCK/MLC20 pathway cascades (Wong et al., 2020). Here, MYL12B is linked to Dysmenorrhea.